SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-22-053250
Filing Date
2022-09-01
Accepted
2022-09-01 17:15:08
Documents
3
Period of Report
2022-10-13

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0822_adialpharma.htm DEF 14A 1112957
2 GRAPHIC tadial_logo.jpg GRAPHIC 138070
3 GRAPHIC tproxy_001.jpg GRAPHIC 1328803
  Complete submission text file 0001213900-22-053250.txt   3135074
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38323 | Film No.: 221221752
SIC: 2834 Pharmaceutical Preparations